PreveCeutical Medical Inc. (CSE:PREV)

Canada flag Canada · Delayed Price · Currency is CAD
0.0200
0.00 (0.00%)
At close: Feb 27, 2026
Market Cap11.96M +10.4%
Revenue (ttm)n/a
Net Income-3.12M
EPS-0.01
Shares Out598.19M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume26,300
Average Volume127,967
Open0.0200
Previous Close0.0200
Day's Range0.0200 - 0.0200
52-Week Range0.0150 - 0.0600
Beta-0.03
RSI46.97
Earnings DateApr 24, 2026

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating ... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Stephen Van Deventer
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PREV
Full Company Profile

Financial Performance

Financial Statements